KRM Ayurveda
NSE: KRMAYURVED · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock KRM Ayurveda's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
KRM Ayurveda Limited operates an integrated healthcare platform that combines multispecialty Ayurvedic hospitals, clinics, and teleconsultation services. The company also maintains in-house manufacturing capabilities for Ayurvedic medicinal products.
Business Model
The company generates revenue through the provision of clinical healthcare services across its hospital network and the sale of proprietary Ayurvedic medicines manufactured in-house.
Growth Outlook
Growth is expected to be driven by the expansion of its hospital and clinic network across India and the scaling of its teleconsultation services.
Key Risks
- Regulatory Compliance. The company faces risks related to evolving regulations governing Ayurvedic medicine manufacturing and healthcare service standards in India.
- Market Competition. The healthcare sector is highly competitive, with increasing pressure from both traditional pharmaceutical firms and emerging wellness platforms.
- Operational Scalability. Maintaining consistent quality of care and product efficacy while rapidly expanding the hospital and clinic network presents significant operational challenges.
Start your research today
Unlock AI insights, financials, peers and live data on KRM Ayurveda and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
KRM AyurvedaKRMAYURVED | ₹644 Cr | — | — | — | 30.0% | — | — | — |
Kilitch Drugs (India) LimitedKILITCH | ₹775 Cr | 17.43 | 17.72 | 14.0% | 20.2% | 12.1% | 15.6% | -36.5% |
Amanta HealthcarAMANTA | ₹735 Cr | 45.77 | 14.20 | — | 21.5% | 6.7% | 9.9% | +39.7% |
Zim LaboratoriesZIMLAB | ₹715 Cr | 167.10 | 20.79 | 7.6% | 9.9% | 1.3% | 5.7% | +91.2% |
Valiant Laboratories LimitedVALIANTLAB | ₹658 Cr | 42.40 | 19.55 | 89.6% | 11.7% | 5.9% | 8.0% | +50.1% |
Influx Health.INFLUX | ₹655 Cr | — | — | — | 20.0% | — | — | +51.5% |
As of Mar 2026
Financials
KRM Ayurveda
NSE: KRMAYURVED · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock KRM Ayurveda's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
KRM Ayurveda Limited operates an integrated healthcare platform that combines multispecialty Ayurvedic hospitals, clinics, and teleconsultation services. The company also maintains in-house manufacturing capabilities for Ayurvedic medicinal products.
Business Model
The company generates revenue through the provision of clinical healthcare services across its hospital network and the sale of proprietary Ayurvedic medicines manufactured in-house.
Growth Outlook
Growth is expected to be driven by the expansion of its hospital and clinic network across India and the scaling of its teleconsultation services.
Key Risks
- Regulatory Compliance. The company faces risks related to evolving regulations governing Ayurvedic medicine manufacturing and healthcare service standards in India.
- Market Competition. The healthcare sector is highly competitive, with increasing pressure from both traditional pharmaceutical firms and emerging wellness platforms.
- Operational Scalability. Maintaining consistent quality of care and product efficacy while rapidly expanding the hospital and clinic network presents significant operational challenges.
Start your research today
Unlock AI insights, financials, peers and live data on KRM Ayurveda and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026